ImmuCell Corp. (ICCC)
5.57
+0.09
(+1.64%)
USD |
NASDAQ |
Dec 09, 16:00
5.70
+0.13
(+2.33%)
After-Hours: 20:00
ImmuCell Market Cap: 50.39M for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| IDEXX Laboratories, Inc. | 55.82B |
| NovaBay Pharmaceuticals, Inc. | 228.08M |
| Palatin Technologies, Inc. | 25.56M |
| Theriva Biologics, Inc. | 7.524M |
| Oragenics, Inc. | 0.8106M |
Market Cap Related Metrics
| PE Ratio | 21.51 |
| PS Ratio | 1.805 |
| Price to Book Value | 1.691 |
| Price to Free Cash Flow | 70.07 |
| Price | 5.57 |
| Earnings Yield | 4.65% |
| Operating PE Ratio | 21.52 |
| Normalized PE Ratio | 21.51 |